SBIO

ALPS Medical Breakthroughs ETF

Up$33.01
+$0.34
(+1.04%)
As of 4:10:00 PM EDT | 10/16/19  |  Market Closed

SBIO Trading Data

Open

$32.83

Low Price

$32.8

High Price

$33.12

Previous Last Price

$32.67

Bid Size

$33 X 300

Ask Size

$36.31 X 500

SBIO Portfolio Data

AUM

$163,550,000

Shares

5,000

PE Ratio

0

Price / Book Ratio

3.92

Expense Ratio

0.5

Net Asset Value

$32.71

Volume

Volume

41,785

Avg. Volume (YDT)

37,096

Dollar Volume

$1,143,306

Weekly Avg. Volume

28,957

Monthly Avg. Volume

34,374

Quarterly Avg. Volume

29,451

SBIO Fund Description

The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the Poliwogg Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.

SBIO Chart

SBIO Summary

Fund Family

ALPS Holdings

Tracks This Index

ALPS Medical Breakthroughs ETF

Inception Date

2015-01-05

Asset Class

Portfolio-Multi Asset

Asset Class Size

Healthcare

SBIO Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

SBIO Holdings

Top 10 Holdings

ALPS Medical Breakthroughs ETF (SBIO)
0%
%
%
%
%
%
%
%
%
%

Total SBIO Holdings

Total Holdings: 1

ALPS Medical Breakthroughs ETF (SBIO)
0%

SBIO Technicals

Alpha

1.86

Beta

1.6

Leverage

Long

Standard Deviation

2.21

SBIO Dividends

Dividend Date

2018-12-20

Latest Dividend

0.784

Annual Dividend

0.78

Annual Dividend Rate

0.78

Annual Dividend Yield

2.4

SBIO Performance

YTD Return

17.31%

1 Year Return

-9.34%

3 Year Return

38.14%

5 Year Return

0%

10 Year Return

31.52%

SBIO Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.